Sh Fosun Pharma traded at 45.99 this Friday July 1st, increasing 1.90 or 4.31 percent since the previous trading session. Looking back, over the last four weeks, Sh Fosun Pharma gained 8.01 percent. Over the last 12 months, its price fell by 36.13 percent. Looking ahead, we forecast Sh Fosun Pharma to be priced at 41.96 by the end of this quarter and at 38.45 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
Daily Change

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Peers Price Day Year
Cspc Pharmaceutical 7.79 0.16 2.10% -29.44%
Sino Biopharmaceutical Ltd 4.97 0.28 5.97% -33.47%
Jiangsu Hengrui Me. 38.80 1.71 4.61% -42.01%
Sh Pharmaceutical 17.99 -0.09 -0.50% -13.43%
WuXi AppTec Co Ltd 102.60 -1.39 -1.34% -33.83%

Indexes Price Day Year
SHANGHAI 3388 -10.98 -0.32% -3.73%
SHANGHAI 50 3045 -13.13 -0.43% -10.65%

Sh Fosun Pharma
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood system, anti-tumor and anti-infection diseases. The Company is also engaged in medical equipment and medical diagnosis business, as well as the provision of medical services. It distributes its products primarily in domestic and overseas markets.